Adelaide Research & Scholarship: Search

Search

Search:
for

Current filters:

Start a new search

Add filters:

Results/Page | Sort items by In order Authors/record

Results 1-10 of 14 (Search time: 0.002 seconds).

previous
1
2
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2019	APOMAB antibody-drug conjugates targeting dead tumor cells are effective in vivo	Staudacher, A.H.; Li, Y.; Liapis, V.; Hou, J.J.C.; Chin, D.; Dolezal, O.; Adams, T.E.; van Berkel, P.H.; Brown, M.P.
	2019	OBI-3424, a novel AKR1c3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALL	Evans, K.; Duan, J.X.; Pritchard, T.; Jones, C.D.; McDermott, L.; Gu, Z.; Toscan, C.E.; El-Zein, N.; Mayoh, C.; Erickson, S.W.; Guo, Y.; Meng, F.; Jung, D.; Rathi, K.S.; Roberts, K.G.; Mullighan, C.G.; Shia, C.S.; Pearce, T.; Teicher, B.A.; Smith, M.A.; et al.
	2017	Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancer	Ponnusamy, S.; Coss, C.; Thiyagarajan, T.; Watts, K.; Hwang, D.-J.; He, Y.; Selth, L.; McEwan, I.; Duke, C.; Pagadala, J.; Singh, G.; Wake, R.; Ledbetter, C.; Tilley, W.; Moldoveanu, T.; Dalton, J.; Miller, D.; Narayanan, R.
	2019	Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma	Neubauer, H.A.; Tea, M.N.; Zebol, J.R.; Gliddon, B.L.; Stefanidis, C.; Moretti, P.A.B.; Pitman, M.R.; Costabile, M.; Kular, J.; Stringer, B.W.; Day, B.W.; Samuel, M.S.; Bonder, C.S.; Powell, J.A.; Pitson, S.M.
	2019	Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia	Bell, C.C.; Fennell, K.A.; Chan, Y.C.; Rambow, F.; Yeung, M.M.; Vassiliadis, D.; Lara, L.; Yeh, P.; Martelotto, L.G.; Rogiers, A.; Kremer, B.E.; Barbash, O.; Mohammad, H.P.; Johanson, T.M.; Burr, M.L.; Dhar, A.; Karpinich, N.; Tian, L.; Tyler, D.S.; MacPherson, L.; et al.
	2013	Next-Generation Sequence Analysis of Cancer Xenograft Models	Rossello, F.J.; Tothill, R.W.; Britt, K.; Marini, K.D.; Falzon, J.; Thomas, D.M.; Peacock, C.D.; Marchionni, L.; Li, J.; Bennett, S.; Tantoso, E.; Brown, T.; Chan, P.; Martelotto, L.G.; Watkins, D.N.; Coleman, W.B.
	2018	Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy	Marini, K.D.; Croucher, D.R.; McCloy, R.A.; Vaghjiani, V.; Gonzalez-Rajal, A.; Hastings, J.F.; Chin, V.; Szczepny, A.; Kostyrko, K.; Marquez, C.; Samantha, W.; Jayasekara, N.; Alamgeer, M.; Boolell, V.; Han, J.Z.R.; Waugh, T.; Lee, H.C.; Oakes, S.R.; Kumar, B.; Harrison, C.A.; et al.
	2015	Progesterone receptor modulates ERα action in breast cancer	Mohammed, H.; Russell, I.; Stark, R.; Rueda, O.; Hickey, T.; Tarulli, G.; Serandour, A.; Birrell, S.; Bruna, A.; Saadi, A.; Menon, S.; Hadfield, J.; Pugh, M.; Raj, G.; Brown, G.; D'Santos, C.; Robinson, J.; Silva, G.; Launchbury, R.; Perou, C.; et al.
	2016	GD2-specific CAR T cells undergo potent activation and deletion following antigen encounter but can be protected from activation-induced cell death by PD-1 blockade	Gargett, T.; Yu, W.; Dotti, G.; Yvon, E.; Christo, S.; Hayball, J.; Lewis, I.; Brenner, M.; Brown, M.
	2013	Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer	Ravindranathan, P.; Lee, T.; Yang, L.; Centenera, M.; Butler, L.; Tilley, W.; Hsieh, J.; Ahn, J.; Raj, G.